Som følge af en potentiel risiko for additive hepatotoxiske virkninger anbefales det, at alkoholindtagelse undgås under behandling med leflunomid.
Due to a potential for additive hepatotoxic effects, it is recommended that alcohol consumption be avoided during treatment with leflunomide.